Morphine-induced TSH release in normal and hypothyroid subjects

Area of Science:

• Endocrinology
• Neuropharmacology

Background:

• Opioid agonists like morphine can influence endocrine function.
• Thyroid-stimulating hormone (TSH) and prolactin (PRL) are key pituitary hormones with complex regulatory pathways.

Purpose of the Study:

• To investigate the effects of morphine and naloxone on serum TSH and PRL levels.
• To compare these effects in hypothyroid patients and normal volunteers.

Main Methods:

• Administered intravenous morphine (10 mg) and naloxone (10 mg) to hypothyroid patients and normal volunteers.
• Measured serum TSH and PRL levels before and after drug administration.
• Evaluated the impact of naloxone pretreatment on morphine's effects.
• Assessed morphine's effect on TRH-stimulated TSH and PRL release in euthyroid volunteers.

Main Results:

• Morphine administration caused a significant increase in serum TSH and PRL in all subjects.
• The increase in PRL was similar between hypothyroid and normal groups; TSH increase was more pronounced in hypothyroid subjects.
• Naloxone pretreatment completely blocked morphine's stimulatory effects on TSH and PRL.
• Naloxone alone did not significantly alter TSH or PRL secretion.
• Morphine enhanced TSH and PRL responses to TRH stimulation.

Conclusions:

• Morphine exerts a direct stimulatory effect on TSH and PRL secretion.
• Opioid receptors appear to play a role in the regulation of TSH and PRL release.
• These findings highlight the neuroendocrine impact of opioid agonists.